Skip to main content
SpringerLink
Log in

Myocardial Protection During Acute Myocardial Infarction: The Need for a Simple Large Randomized Trial with GIK

  • Editorial Board
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ryan TJ, Antman EM, Brooks NH, et al. 1999 Update: ACC/AHA Guidelines for the Management of Patients with Acute Myocardial Infarction: Executive Summary and Recommendations: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999;100:1016-1030.

    PubMed  Google Scholar 

  2. Sodi-Pallares D, Testelli MR, Fischleder BL. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol 1962;9:166-181.

    PubMed  Google Scholar 

  3. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials. Circulation 1997;96:1152-1156.

    PubMed  Google Scholar 

  4. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.

    PubMed  Google Scholar 

  5. Diaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998;98:2227-2234.

    PubMed  Google Scholar 

  6. Ceremuzynski L, Budaj A, Czepiel A, et al. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: Results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther 1999;13:191-200.

    PubMed  Google Scholar 

  7. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium in acute myocardial infarction. Lancet 1999;353:1968.

    Google Scholar 

  8. Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med 1984;3:409-422.

    PubMed  Google Scholar 

  9. Opie IH. Proof that above-insulin potasium provides metabolic protection of ischarmic myocardium? Lancet 1999;353(9155):768-769.

    PubMed  Google Scholar 

  10. Apstein CS, Opie LH. Glucose-insulin potasium (GIK) for acute myocardial intarction.Anegative study with a positive value. Cardiovasic Drugs Ther. 1996;13(3):185-189.

    Google Scholar 

  11. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-1504.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto Cardiovascular de Rosario, ECLA (Estudios Cardiológicos Latinoamérica), Rosario, Argentina

    Rafael Díaz

Authors
  1. Rafael Díaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Díaz, R. Myocardial Protection During Acute Myocardial Infarction: The Need for a Simple Large Randomized Trial with GIK. Cardiovasc Drugs Ther 14, 561–563 (2000). https://doi.org/10.1023/A:1007825208314

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007825208314

Search

Navigation